{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:24:28Z","timestamp":1790745868525,"version":"4.1.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The aims of this study were to investigate the relationship between the type of autoantibody and gene expression profile in skin lesions from patients with SSc, and to identify specific dysregulated pathways in SSc patients compared with healthy controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Sixty-one patients with SSc from the Genetics vs Environment in Scleroderma Outcome Study cohort and 36 healthy controls were included in this study. Differentially expressed genes were extracted and functional enrichment and pathway analysis were conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with healthy controls, lists containing 2, 71, 10, 144 and 78 differentially expressed genes were created for patients without specific autoantibody, ACA, anti-U1 RNP antibody (RNP), anti-RNA polymerase III antibody (RNAP) and anti-topoisomerase I antibody (ATA), respectively. While part of the enriched pathways overlapped, distinct pathways were identified except in those patients lacking specific autoantibody. The distinct enriched pathways included \u2018keratinocyte differentiation\u2019 for ACA, \u2018nuclear factor \u03baB signalling\u2019 and \u2018cellular response to TGF-\u03b2 stimulus\u2019 for RNAP, \u2018interferon \u03b1\/\u03b2 signalling\u2019 for RNP, and \u2018cellular response to stress\u2019 for ATA. Cell type signature score analysis revealed that macrophages\/monocytes, endothelial cells and fibroblasts were associated with ACA, RNAP, ATA and the severity of the SSc skin lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Pathogenic pathways were identified according to the type of autoantibody by leveraging gene expression data of patients and controls from a multicentre cohort. The current study may promote the search for new therapeutic targets for SSc.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa447","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T23:19:03Z","timestamp":1593559143000},"page":"929-939","source":"Crossref","is-referenced-by-count":15,"title":["Association of differentially expressed genes and autoantibody type in patients with systemic sclerosis"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9927-7936","authenticated-orcid":false,"given":"Jun","family":"Inamo","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,10]]},"reference":[{"key":"2021020119053249300_keaa447-B1","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/1529-0131(200011)43:11<2445::AID-ANR11>3.0.CO;2-Q","article-title":"Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial","volume":"43","author":"Clements","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2021020119053249300_keaa447-B2","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1002\/art.39289","article-title":"Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis","volume":"67","author":"Assassi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2021020119053249300_keaa447-B3","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/annrheumdis-2019-215894","article-title":"Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile","volume":"79","author":"Skaug","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2021020119053249300_keaa447-B4","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1002\/art.24681","article-title":"Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: analysis of three large multicenter, double-blind, randomized controlled trials","volume":"60","author":"Amjadi","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2021020119053249300_keaa447-B5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.autrev.2012.07.005","article-title":"Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis","volume":"12","author":"Villalta","year":"2012","journal-title":"Autoimmun Rev"},{"key":"2021020119053249300_keaa447-B6","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/08916934.2017.1357699","article-title":"Disease-related autoantibody profile in patients with systemic sclerosis","volume":"50","author":"Liaskos","year":"2017","journal-title":"Autoimmunity"},{"key":"2021020119053249300_keaa447-B7","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3899\/jrheum.091048","article-title":"Association of RNA polymerase III antibodies with scleroderma renal crisis","volume":"37","author":"Nguyen","year":"2010","journal-title":"J Rheumatol"},{"key":"2021020119053249300_keaa447-B8","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/annrheumdis-2013-204487","article-title":"Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis","volume":"74","author":"Moinzadeh","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2021020119053249300_keaa447-B9","first-page":"S29","article-title":"Assessment of kidney involvement","volume":"21","author":"Steen","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"2021020119053249300_keaa447-B10","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.semarthrit.2014.11.006","article-title":"Antinuclear antibody-negative systemic sclerosis","volume":"44","author":"Salazar","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"2021020119053249300_keaa447-B11","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/ar3125","article-title":"Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort","volume":"12","author":"Assassi","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"2021020119053249300_keaa447-B12","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"65","author":"Van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2021020119053249300_keaa447-B13","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"2021020119053249300_keaa447-B14","first-page":"1281","article-title":"Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis","volume":"22","author":"Clements","year":"1995","journal-title":"J Rheumatol"},{"key":"2021020119053249300_keaa447-B15","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol"},{"key":"2021020119053249300_keaa447-B16","doi-asserted-by":"crossref","first-page":"i436","DOI":"10.1093\/bioinformatics\/btz363","article-title":"Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology","volume":"35","author":"Sturm","year":"2019","journal-title":"Bioinformatics"},{"key":"2021020119053249300_keaa447-B17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1152\/japplphysiol.01360.2004","article-title":"Expression of mutant human epidermal receptor 3 attenuates lung fibrosis and improves survival in mice","volume":"99","author":"Nethery","year":"2005","journal-title":"J Appl Physiol"},{"key":"2021020119053249300_keaa447-B18","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1096\/fj.07-083857","article-title":"Transgelin is a direct target of TGF-\u03b2\/Smad3-dependent epithelial cell migration in lung fibrosis","volume":"22","author":"Yu","year":"2008","journal-title":"FASEB J"},{"key":"2021020119053249300_keaa447-B19","doi-asserted-by":"crossref","first-page":"e1000371","DOI":"10.1371\/journal.ppat.1000371","article-title":"Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis","volume":"5","author":"Pesce","year":"2009","journal-title":"PLoS Pathog"},{"key":"2021020119053249300_keaa447-B20","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0002-9440(10)61243-6","article-title":"Transforming growth factor-\u03b2 regulation of epithelial tight junction proteins enhances barrier function and blocks enterohemorrhagic Escherichia coli O157:H7-induced increased permeability","volume":"167","author":"Howe","year":"2005","journal-title":"Am J Pathol"},{"key":"2021020119053249300_keaa447-B21","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1038\/s41467-019-12760-y","article-title":"GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways","volume":"10","author":"L\u00f3pez-Isac","year":"2019","journal-title":"Nat Commun"},{"key":"2021020119053249300_keaa447-B22","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1189\/jlb.0313153","article-title":"Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation","volume":"94","author":"Muralidharan","year":"2013","journal-title":"J Leukoc Biol"},{"key":"2021020119053249300_keaa447-B23","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/art.37988","article-title":"Review: evidence that systemic sclerosis is a vascular disease","volume":"65","author":"Matucci-Cerinic","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2021020119053249300_keaa447-B24","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1755-1536-5-S1-S5","article-title":"The myofibroblast, multiple origins for major roles in normal and pathological tissue repair","volume":"5","author":"Micallef","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"2021020119053249300_keaa447-B25","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat Med"},{"key":"2021020119053249300_keaa447-B26","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1172\/JCI77958","article-title":"Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients","volume":"125","author":"Rice","year":"2015","journal-title":"J Clin Invest"},{"key":"2021020119053249300_keaa447-B27","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1136\/annrheumdis-2016-210503","article-title":"Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)","volume":"76","author":"Herrick","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021020119053249300_keaa447-B28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11926-015-0554-8","article-title":"Macrophage involvement in systemic sclerosis: do we need more evidence?","volume":"18","author":"Stifano","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"2021020119053249300_keaa447-B29","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.autrev.2017.05.024","article-title":"The role of endothelial cells in the vasculopathy of systemic sclerosis: a systematic review","volume":"16","author":"Mostmans","year":"2017","journal-title":"Autoimmun Rev"},{"key":"2021020119053249300_keaa447-B30","doi-asserted-by":"crossref","first-page":"4569826","DOI":"10.1155\/2019\/4569826","article-title":"Systemic sclerosis pathogenesis and emerging therapies, beyond the fibroblast","volume":"2019","author":"Sierra-Sep\u00falveda","year":"2019","journal-title":"Biomed Res Int"},{"key":"2021020119053249300_keaa447-B31","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1165\/rcmb.2013-0152OC","article-title":"Endothelial cells recruit macrophages and contribute to a fibrotic milieu in bleomycin lung injury","volume":"49","author":"Leach","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2021020119053249300_keaa447-B32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fimmu.2015.00167","article-title":"Autoantibodies in systemic sclerosis: unanswered questions","volume":"6","author":"Kayser","year":"2015","journal-title":"Front Immunol"},{"key":"2021020119053249300_keaa447-B33","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/jid.2011.472","article-title":"Intrinsic gene expression subsets of diffuse cutaneous systemic sclerosis are stable in serial skin biopsies","volume":"132","author":"Pendergrass","year":"2012","journal-title":"J Invest Dermatol"},{"key":"2021020119053249300_keaa447-B34","doi-asserted-by":"crossref","first-page":"12319","DOI":"10.1073\/pnas.1635114100","article-title":"Systemic and cell type-specific gene expression patterns in scleroderma skin","volume":"100","author":"Whitfield","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021020119053249300_keaa447-B35","doi-asserted-by":"crossref","first-page":"e2696","DOI":"10.1371\/journal.pone.0002696","article-title":"Molecular subsets in the gene expression signatures of scleroderma skin","volume":"3","author":"Milano","year":"2008","journal-title":"PLoS One"},{"key":"2021020119053249300_keaa447-B36","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1038\/jid.2013.130","article-title":"Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis","volume":"133","author":"Hinchcliff","year":"2013","journal-title":"J Invest Dermatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/2\/929\/36167863\/keaa447.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/2\/929\/36167863\/keaa447.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T22:23:33Z","timestamp":1612304613000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/2\/929\/5903866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,10]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,9,10]]},"published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa447","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.04.12.20063131","asserted-by":"object"}]},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2,1]]},"published":{"date-parts":[[2020,9,10]]}}}